메뉴 건너뛰기




Volumn 116, Issue 18, 2010, Pages 3384-3386

FNAIT: The fetus pleads guilty!

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATERNAL ANTIBODY;

EID: 78149317645     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-08-299404     Document Type: Note
Times cited : (3)

References (10)
  • 2
    • 78149300934 scopus 로고    scopus 로고
    • Animal model of fetal and neonatal immune thrombocytopenia: Role of neonatal Fc receptor in the pathogenesis and therapy
    • Chen P, Li C, Lang S, et al. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood. 2010;116(18):3660-3668.
    • (2010) Blood , vol.116 , Issue.18 , pp. 3660-3668
    • Chen, P.1    Li, C.2    Lang, S.3
  • 3
    • 0030468012 scopus 로고    scopus 로고
    • Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: A prospective comparison of effectiveness and costs
    • Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol. 1996;13(7):423-431. (Pubitemid 26425206)
    • (1996) American Journal of Perinatology , vol.13 , Issue.7 , pp. 423-431
    • Durand-Zaleski, I.1    Schlegel, N.2    Blum-Boisgard, C.3    Uzan, S.4    Dreyfus, M.5    Kaplan, C.6
  • 5
    • 34548439081 scopus 로고    scopus 로고
    • Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: A randomized controlled trial
    • Berkowitz RL, Lesser ML, McFarland JG, et al. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol. 2007;110(2 Pt 1):249-255.
    • (2007) Obstet Gynecol , vol.110 , Issue.2 PART 1 , pp. 249-255
    • Berkowitz, R.L.1    Lesser, M.L.2    McFarland, J.G.3
  • 6
    • 48749129395 scopus 로고    scopus 로고
    • Developing recombinant HPA-1a-specific antibodies with abrogated Fc-gamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia
    • Ghevaert C, Wilcox DA, Fang J, et al. Developing recombinant HPA-1a-specific antibodies with abrogated Fc-gamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest. 2008;118(8):2929-2938.
    • (2008) J Clin Invest , vol.118 , Issue.8 , pp. 2929-2938
    • Ghevaert, C.1    Wilcox, D.A.2    Fang, J.3
  • 7
    • 33645531319 scopus 로고    scopus 로고
    • A novel murine model of fetal and neonatal alloimmune thrombocytopenia: Response to intravenous IgG therapy
    • Ni H, Chen P, Spring CM, et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood. 2006;107(7):2976-2983.
    • (2006) Blood , vol.107 , Issue.7 , pp. 2976-2983
    • Ni, H.1    Chen, P.2    Spring, C.M.3
  • 8
    • 0015421358 scopus 로고
    • The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat
    • Jones EA, Waldmann TA. The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest. 1972;51(11):2916-2927.
    • (1972) J Clin Invest , vol.51 , Issue.11 , pp. 2916-2927
    • Jones, E.A.1    Waldmann, T.A.2
  • 9
    • 77954680599 scopus 로고    scopus 로고
    • The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
    • Sesarman A, Vidarsson G, Sitaru C. The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases. Cell Mol Life Sci. 2010;67(15):2533-2550.
    • (2010) Cell Mol Life Sci , vol.67 , Issue.15 , pp. 2533-2550
    • Sesarman, A.1    Vidarsson, G.2    Sitaru, C.3
  • 10
    • 40749083596 scopus 로고    scopus 로고
    • The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: What do we really know?
    • Crow AR, Lazarus AH. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Transfus Med Rev. 2008;22(2):103-116.
    • (2008) Transfus Med Rev , vol.22 , Issue.2 , pp. 103-116
    • Crow, A.R.1    Lazarus, A.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.